 Kristen DeSanto
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofascial Pain Syndromes | 2 | 2023 | 12 | 1.530 |
Why?
| | Acupuncture Therapy | 2 | 2023 | 21 | 1.520 |
Why?
| | Low Back Pain | 2 | 2023 | 108 | 1.380 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 346 | 1.020 |
Why?
| | Workplace Violence | 1 | 2025 | 12 | 0.910 |
Why?
| | Health Facilities | 1 | 2025 | 85 | 0.870 |
Why?
| | Patient Education as Topic | 2 | 2022 | 777 | 0.860 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2023 | 4 | 0.810 |
Why?
| | Nutrition Therapy | 1 | 2023 | 37 | 0.780 |
Why?
| | Fibromyalgia | 1 | 2023 | 52 | 0.770 |
Why?
| | Naltrexone | 1 | 2023 | 115 | 0.710 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 260 | 0.660 |
Why?
| | Postmenopause | 1 | 2023 | 394 | 0.650 |
Why?
| | Water Sports | 1 | 2020 | 3 | 0.650 |
Why?
| | Hallucinogens | 1 | 2022 | 111 | 0.630 |
Why?
| | Antipsychotic Agents | 1 | 2022 | 211 | 0.620 |
Why?
| | Analgesics | 2 | 2022 | 231 | 0.620 |
Why?
| | Ganglion Cysts | 1 | 2020 | 10 | 0.610 |
Why?
| | Wound Healing | 1 | 2022 | 355 | 0.610 |
Why?
| | Health Personnel | 2 | 2025 | 757 | 0.600 |
Why?
| | Wrist | 1 | 2020 | 60 | 0.580 |
Why?
| | Behavior Therapy | 1 | 2022 | 296 | 0.580 |
Why?
| | Diuretics | 1 | 2019 | 68 | 0.580 |
Why?
| | Spironolactone | 1 | 2019 | 40 | 0.570 |
Why?
| | Memory | 1 | 2021 | 297 | 0.550 |
Why?
| | Clostridium Infections | 1 | 2019 | 74 | 0.540 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 109 | 0.540 |
Why?
| | Glycemic Index | 1 | 2018 | 26 | 0.540 |
Why?
| | Viscosupplements | 1 | 2018 | 11 | 0.540 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 113 | 0.530 |
Why?
| | Communication | 3 | 2021 | 977 | 0.520 |
Why?
| | Humans | 54 | 2026 | 145763 | 0.520 |
Why?
| | Musculoskeletal System | 1 | 2018 | 54 | 0.510 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2602 | 0.510 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 468 | 0.500 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 177 | 0.500 |
Why?
| | Testosterone | 1 | 2021 | 416 | 0.490 |
Why?
| | Health Promotion | 2 | 2026 | 775 | 0.490 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 237 | 0.480 |
Why?
| | Randomized Controlled Trials as Topic | 6 | 2024 | 1751 | 0.480 |
Why?
| | Chagas Disease | 3 | 2021 | 42 | 0.470 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 226 | 0.450 |
Why?
| | Cannabis | 1 | 2022 | 510 | 0.440 |
Why?
| | Sleep | 1 | 2022 | 889 | 0.440 |
Why?
| | Pain Measurement | 3 | 2023 | 562 | 0.430 |
Why?
| | Osteoarthritis, Knee | 1 | 2018 | 281 | 0.410 |
Why?
| | Athletic Injuries | 1 | 2020 | 573 | 0.390 |
Why?
| | Glucocorticoids | 1 | 2018 | 532 | 0.390 |
Why?
| | Skin Neoplasms | 1 | 2020 | 852 | 0.380 |
Why?
| | Asthma | 1 | 2023 | 1797 | 0.350 |
Why?
| | Upper Extremity | 2 | 2024 | 113 | 0.340 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 107 | 0.330 |
Why?
| | Hypertension | 1 | 2019 | 1276 | 0.320 |
Why?
| | Sexual and Gender Minorities | 2 | 2025 | 262 | 0.310 |
Why?
| | Palliative Care | 4 | 2024 | 1022 | 0.290 |
Why?
| | Cardiomyopathies | 2 | 2021 | 335 | 0.250 |
Why?
| | Pain Management | 2 | 2023 | 411 | 0.250 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2191 | 0.240 |
Why?
| | Advance Care Planning | 2 | 2021 | 244 | 0.240 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 595 | 0.230 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2026 | 46 | 0.230 |
Why?
| | Fruit | 1 | 2026 | 146 | 0.230 |
Why?
| | Sepsis | 2 | 2022 | 664 | 0.220 |
Why?
| | Vegetables | 1 | 2026 | 162 | 0.220 |
Why?
| | Urologic Surgical Procedures | 1 | 2026 | 118 | 0.220 |
Why?
| | Loneliness | 1 | 2025 | 69 | 0.210 |
Why?
| | Peripheral Nerve Injuries | 1 | 2024 | 38 | 0.210 |
Why?
| | Risk Assessment | 3 | 2025 | 3752 | 0.210 |
Why?
| | Milk Hypersensitivity | 1 | 2024 | 18 | 0.210 |
Why?
| | Population Groups | 2 | 2021 | 56 | 0.210 |
Why?
| | Parental Leave | 1 | 2024 | 27 | 0.210 |
Why?
| | Egg Hypersensitivity | 1 | 2024 | 28 | 0.210 |
Why?
| | Muscle Cramp | 1 | 2023 | 7 | 0.200 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 66 | 0.200 |
Why?
| | Urinary Bladder | 1 | 2026 | 196 | 0.200 |
Why?
| | Social Environment | 1 | 2025 | 252 | 0.200 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 16 | 0.200 |
Why?
| | Amitriptyline | 1 | 2023 | 24 | 0.200 |
Why?
| | Preconception Care | 1 | 2024 | 50 | 0.200 |
Why?
| | Live Birth | 1 | 2024 | 81 | 0.200 |
Why?
| | Desensitization, Immunologic | 1 | 2024 | 89 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 185 | 0.190 |
Why?
| | Trigger Points | 1 | 2023 | 15 | 0.190 |
Why?
| | Magnesium | 1 | 2023 | 157 | 0.190 |
Why?
| | Urogenital Abnormalities | 1 | 2023 | 71 | 0.190 |
Why?
| | Quetiapine Fumarate | 1 | 2022 | 26 | 0.180 |
Why?
| | Fertility | 1 | 2024 | 174 | 0.180 |
Why?
| | Aripiprazole | 1 | 2022 | 20 | 0.180 |
Why?
| | Stroke | 2 | 2022 | 1271 | 0.180 |
Why?
| | Rectum | 1 | 2023 | 182 | 0.180 |
Why?
| | Administration, Inhalation | 1 | 2023 | 571 | 0.180 |
Why?
| | Job Satisfaction | 1 | 2024 | 238 | 0.180 |
Why?
| | Leg | 1 | 2023 | 242 | 0.170 |
Why?
| | Transition to Adult Care | 1 | 2023 | 103 | 0.170 |
Why?
| | Chagas Cardiomyopathy | 1 | 2021 | 27 | 0.170 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1582 | 0.170 |
Why?
| | Insulin, Isophane | 1 | 2021 | 22 | 0.170 |
Why?
| | Benzodiazepines | 1 | 2022 | 168 | 0.160 |
Why?
| | Back Injuries | 1 | 2020 | 5 | 0.160 |
Why?
| | Colon | 1 | 2023 | 309 | 0.160 |
Why?
| | Wounds, Gunshot | 1 | 2024 | 258 | 0.160 |
Why?
| | Dermoscopy | 1 | 2020 | 11 | 0.160 |
Why?
| | Drowning | 1 | 2020 | 7 | 0.160 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 1043 | 0.160 |
Why?
| | Insulin Glargine | 1 | 2021 | 88 | 0.160 |
Why?
| | Aged, 80 and over | 5 | 2021 | 8346 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1217 | 0.160 |
Why?
| | Facial Injuries | 1 | 2020 | 25 | 0.160 |
Why?
| | Neck Injuries | 1 | 2020 | 21 | 0.160 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 484 | 0.160 |
Why?
| | Torso | 1 | 2020 | 36 | 0.160 |
Why?
| | Attitude to Computers | 1 | 2020 | 28 | 0.160 |
Why?
| | Health Information Exchange | 1 | 2020 | 23 | 0.150 |
Why?
| | Ambulances | 1 | 2020 | 52 | 0.150 |
Why?
| | Bone and Bones | 1 | 2022 | 318 | 0.150 |
Why?
| | Nurse's Role | 1 | 2021 | 149 | 0.150 |
Why?
| | Patient Selection | 1 | 2024 | 739 | 0.150 |
Why?
| | Transgender Persons | 1 | 2023 | 210 | 0.150 |
Why?
| | Intrauterine Devices | 1 | 2019 | 29 | 0.150 |
Why?
| | Pelvis | 1 | 2020 | 125 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 562 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2023 | 584 | 0.150 |
Why?
| | Wearable Electronic Devices | 1 | 2020 | 69 | 0.140 |
Why?
| | Shock, Septic | 1 | 2021 | 227 | 0.140 |
Why?
| | Teaching | 1 | 2021 | 237 | 0.140 |
Why?
| | Patient Readmission | 1 | 2024 | 772 | 0.140 |
Why?
| | Colonoscopy | 1 | 2021 | 264 | 0.140 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 179 | 0.140 |
Why?
| | Volunteers | 1 | 2018 | 39 | 0.140 |
Why?
| | Long-Term Care | 1 | 2019 | 118 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 859 | 0.130 |
Why?
| | Visual Analog Scale | 1 | 2018 | 34 | 0.130 |
Why?
| | Female | 14 | 2025 | 79035 | 0.130 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 58 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 172 | 0.130 |
Why?
| | Pain | 1 | 2023 | 791 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2024 | 488 | 0.130 |
Why?
| | Reproducibility of Results | 1 | 2025 | 3416 | 0.130 |
Why?
| | Cytokines | 2 | 2022 | 2069 | 0.130 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 181 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 782 | 0.130 |
Why?
| | Cooperative Behavior | 1 | 2020 | 463 | 0.120 |
Why?
| | Terminal Care | 1 | 2021 | 283 | 0.120 |
Why?
| | Risk Factors | 5 | 2025 | 10917 | 0.120 |
Why?
| | Library Services | 1 | 2016 | 8 | 0.120 |
Why?
| | Libraries, Medical | 1 | 2016 | 11 | 0.120 |
Why?
| | Antigens, Fungal | 1 | 2016 | 28 | 0.120 |
Why?
| | Cryptococcus | 1 | 2016 | 16 | 0.120 |
Why?
| | Recurrence | 1 | 2020 | 1139 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 450 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 920 | 0.120 |
Why?
| | Meningitis, Cryptococcal | 1 | 2016 | 34 | 0.120 |
Why?
| | Hypoglycemia | 1 | 2021 | 480 | 0.120 |
Why?
| | Vomiting | 1 | 2016 | 131 | 0.120 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 486 | 0.120 |
Why?
| | United States | 6 | 2026 | 16123 | 0.110 |
Why?
| | Hospice Care | 1 | 2019 | 228 | 0.110 |
Why?
| | Survival Analysis | 1 | 2019 | 1378 | 0.110 |
Why?
| | Skin | 1 | 2020 | 754 | 0.110 |
Why?
| | Prevalence | 2 | 2021 | 2874 | 0.110 |
Why?
| | Perception | 1 | 2018 | 378 | 0.110 |
Why?
| | Administration, Oral | 1 | 2018 | 867 | 0.110 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 740 | 0.110 |
Why?
| | Emergency Medical Services | 1 | 2022 | 684 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 788 | 0.110 |
Why?
| | Acute Disease | 1 | 2018 | 1036 | 0.110 |
Why?
| | Aged | 6 | 2024 | 26215 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2028 | 0.110 |
Why?
| | Prognosis | 2 | 2022 | 4329 | 0.100 |
Why?
| | Internship and Residency | 1 | 2024 | 1269 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 644 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 868 | 0.090 |
Why?
| | Critical Illness | 1 | 2019 | 900 | 0.090 |
Why?
| | Adult | 9 | 2025 | 40872 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1101 | 0.090 |
Why?
| | Child | 5 | 2026 | 22739 | 0.090 |
Why?
| | Depression | 1 | 2022 | 1557 | 0.090 |
Why?
| | Blood Glucose | 1 | 2022 | 2344 | 0.090 |
Why?
| | Male | 9 | 2025 | 73003 | 0.080 |
Why?
| | Wounds and Injuries | 1 | 2019 | 962 | 0.080 |
Why?
| | Qualitative Research | 3 | 2026 | 1683 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2383 | 0.080 |
Why?
| | Observational Studies as Topic | 2 | 2021 | 134 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 36302 | 0.070 |
Why?
| | Infant | 1 | 2022 | 10090 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2024 | 11793 | 0.060 |
Why?
| | Nutrition Policy | 1 | 2026 | 57 | 0.060 |
Why?
| | Urinary Catheterization | 1 | 2026 | 35 | 0.060 |
Why?
| | Lung | 1 | 2019 | 4116 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2326 | 0.060 |
Why?
| | Protective Factors | 1 | 2025 | 99 | 0.060 |
Why?
| | Social Isolation | 1 | 2025 | 74 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2123 | 0.050 |
Why?
| | Eggs | 1 | 2024 | 25 | 0.050 |
Why?
| | Organizational Policy | 1 | 2024 | 78 | 0.050 |
Why?
| | Research Design | 2 | 2021 | 1139 | 0.050 |
Why?
| | Cooking | 1 | 2024 | 57 | 0.050 |
Why?
| | Milk | 1 | 2024 | 119 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 81 | 0.050 |
Why?
| | Incidence | 2 | 2021 | 2933 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 119 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 122 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 129 | 0.040 |
Why?
| | Immune Tolerance | 1 | 2024 | 385 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2022 | 219 | 0.040 |
Why?
| | Motivation | 1 | 2026 | 602 | 0.040 |
Why?
| | Allergens | 1 | 2024 | 386 | 0.040 |
Why?
| | Social Support | 1 | 2025 | 651 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 173 | 0.040 |
Why?
| | Technology | 1 | 2021 | 97 | 0.040 |
Why?
| | Canada | 1 | 2021 | 432 | 0.040 |
Why?
| | Uncertainty | 1 | 2021 | 146 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 248 | 0.040 |
Why?
| | Late Onset Disorders | 1 | 2019 | 2 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2021 | 176 | 0.040 |
Why?
| | Triage | 1 | 2022 | 250 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 557 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 466 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 446 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2023 | 495 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 883 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 22573 | 0.030 |
Why?
| | Stroke Volume | 1 | 2021 | 655 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 544 | 0.030 |
Why?
| | Health Education | 1 | 2021 | 346 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 356 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 189 | 0.030 |
Why?
| | Health Information Management | 1 | 2016 | 7 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 668 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 176 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 381 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1496 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1812 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 202 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2016 | 214 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 14251 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17325 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1512 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2967 | 0.020 |
Why?
| | Animals | 2 | 2024 | 38097 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2883 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7215 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 3118 | 0.020 |
Why?
| | Biomedical Research | 1 | 2016 | 719 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3634 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4556 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6085 | 0.010 |
Why?
|
|
DeSanto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|